Terms: = Uterine cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Treatment
5 results:
1. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
[TBL] [Abstract] [Full Text] [Related]
2. Invasive cervical cancer after treatment of CIN.
Herbert A; Culora G; McLean E; Kubba AA;
J Am Soc Cytopathol; 2019; 8(6):324-332. PubMed ID: 31523013
[TBL] [Abstract] [Full Text] [Related]
3. Black and white women in Maryland receive different treatment for cervical cancer.
Fleming S; Schluterman NH; Tracy JK; Temkin SM
PLoS One; 2014; 9(8):e104344. PubMed ID: 25121587
[TBL] [Abstract] [Full Text] [Related]
4. Cervical screening: why young women should be encouraged to be screened.
Herbert A; Holdsworth G; Kubba AA
J Fam Plann Reprod Health Care; 2008 Jan; 34(1):21-5. PubMed ID: 18201402
[TBL] [Abstract] [Full Text] [Related]
5. Radiotherapy for cervical cancer with high-dose rate brachytherapy correlation between tumor size, dose and failure.
Ito H; Kutuki S; Nishiguchi I; Shigematsu N; Kuribayashi T; Uematsu M; Nakayama T; Ka WJ; Takemasa K; Ando Y
Radiother Oncol; 1994 Jun; 31(3):240-7. PubMed ID: 8066207
[TBL] [Abstract] [Full Text] [Related]
